Results 141 to 150 of about 1,030 (166)

Is the usage of intranasal glucocorticosteroids alone in allergic rhinitis sufficient?

Allergy and Asthma Proceedings, 2006
Recently, it is claimed that the usage of the intranasal glucocorticosteroids alone, instead of H1-antihistamines + intranasal glucocorticosteroids, reduces the complaints in moderate-to-severe seasonal allergic rhinitis (SAR). This study aims to evaluate the efficacy of the intranasal glucocorticosteroids alone during the pollen season by using ...
Can, Demet, Demir, Esen, Tanac, Remziye, Gulen, Figen, Veral, Ali   +4 more
openaire   +3 more sources

Adherence to Intranasal Glucocorticosteroid Treatment for Patients with Allergic Rhinitis

Рецепт, 2020
Введение. Аллергический ринит хроническое заболевание слизистой оболочки носа, обусловленное иммуноглобулинами Е (Ig E), проявляющееся чиханием, зудом носа, водянистыми выделениями из носа (ринорея) и заложенностью носа, которые проходят спонтанно или под влиянием лечения.
openaire   +1 more source

Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids

Acta Paediatrica, 1993
Short‐term growth was studied during the grass pollen season with weekly knemometry in 44 schoolchildren with allergic rhinitis. The design was a randomized, parallel group study. After a four‐weeks run‐in period, the children were allocated to six weeks' treatment with either a single im injection of methylprednisolone acetate 60 mg at the beginning ...
O D, Wolthers, S, Pedersen
openaire   +2 more sources

Current status of intranasal glucocorticosteroids in the management of allergic rhinitis

Clinical & Experimental Allergy Reviews, 2008
SummaryGlucocorticosteroids are the most effective drugs for controlling inflammation of allergic rhinitis (AR). Because of their strong pharmacological action, which can be a so‐called ‘double‐edged sword’, glucocorticosteroids are usually taken intranasally so as to reduce their potential for eliciting adverse effects.
openaire   +1 more source

A Study of the Intranasal Glucocorticosteroid Nasonex in the Complex Treatment of Polyposis Rhinosinusitis

Оториноларингология. Восточная Европа
Введение. В основе полипозного риносинусита (ПРС) лежит хронический воспалительный гиперпластический процесс в слизистой оболочке полости носа и околоносовых пазух (ОНП). По данным консенсуса по биологической терапии ПРС в сочетании с бронхиальной астмой (БА) или без нее, являющегося одним из последних согласительных документов Европейского форума по ...
openaire   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly  

Effects of the Novel Intranasal Glucocorticosteroid Gw685698 (200μG Once-daily) on Seasonal Allergic Rhinitis (sar) Symptoms Induced in the Vienna Challenge Chamber Model (vcc)

Journal of Allergy and Clinical Immunology, 2006
openaire   +1 more source